Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Antiphospholipid Syndrome (APS) is an autoimmune disorder where your immune system mistakenly attacks proteins in your blood, making it clot more easily.
This can lead to serious health problems like blood clots in veins and arteries (deep vein thrombosis, pulmonary embolism), strokes, heart attacks, and repeated miscarriages or stillbirths.
It can affect anyone, though it’s more common in women and often diagnosed between ages 20 and 40.
Here’s why donating to the APS Foundation of America, Inc. is so important:
The APS Foundation of America is dedicated to supporting both adult and pediatric research into APS. In 2025, they awarded three $10,000 microgrants to research teams and $10,000 to ICAPA. They also aim to set aside 10% of donations for future research funding.
Education and Awareness: They provide vital information and education about APS to patients, their families, and the general community.
This includes information on diagnosis, symptoms, treatment, and coping.
They also work to raise national awareness for APS, which is the leading cause of stroke in young people and a significant factor in recurrent miscarriages.
The APS Foundation of America offers support and resources for those living with APS, including a network of doctors familiar with the condition and an online forum for communication with other patients.
They advocate for earlier diagnosis and better patient care.
Founded in 2005, the APS Foundation of America is a volunteer-run 501(c)(3) public charity.
They strive to keep administrative costs low, with many members being patients themselves.
They also aim for transparency, with a Charity Navigator score of 98% for accountability and finance.
Your donations help the APS Foundation of America continue its crucial work in fighting this often-misunderstood illness, advancing research, and supporting those affected.
Corporate Donations message us.”
Stay updated with Hemostasis Today.
-
Apr 30, 2026, 18:19Deva Nanda TK: A Practical Overview of Dural Sinuses and The Venous Drainage of the Brain
-
Apr 30, 2026, 18:08Amrit Kaur Kaler: The Hidden Genetic Drivers of Thrombosis
-
Apr 30, 2026, 18:06Alejandro González Veliz: The Most Dangerous Mistake After Getting a Stent
-
Apr 30, 2026, 18:03Carmen Ruiz: First Arterial Mechanical Thrombectomy in New Zealand Using the ARTIX System
-
Apr 30, 2026, 17:52Simon Senanu: von Willebrand Disease May Be Missed Despite Normal Tests
-
Apr 30, 2026, 17:20José Antonio García Erce: Why Healthy Older Adults Should Keep Donating Blood?
-
Apr 30, 2026, 17:13Paul Logan: Decoding the Words ‘He’s on blood thinners’
-
Apr 30, 2026, 17:01Jason Andrade: A Decade-Long Quest Proves Early Ablation Halves Persistent AF Burden
-
Apr 30, 2026, 16:56Oliver Maracic: Could Co-Targeting ALK with FAK/PYK2 Help Mitigate the High VTE Burden Seen in ALK with NSCLC